Patent ID: 11964075
Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
Field: Medical technology (Instruments)
Classification: CPC A  B | IPC A

Claim 0:
1. An injectable composite ink comprising:
a hydrogel continuous phase; and
a plurality of gelatin-containing microgels comprising a hydrogel, the plurality of gelatin-containing microgels comprising the hydrogel being dispersed within the hydrogel continuous phase,
wherein the gelatin-containing microgels comprise gelatin having a bloom strength of between about 200 and about 300,
wherein a concentration of the gelatin in the gelatin-containing microgels is 5% w/v, 10% w/v, or 15% w/v,
wherein hydrogel continuous phase is between about 1 wt % to about 10 wt % of the injectable composite ink,
wherein the gelatin-containing microgels is between about 90 wt % to about 99 wt % of the injectable composite ink, and
wherein the injectable composite ink has a measurable Young's modulus of between 14.4 kPa and 56.8 kPa.